A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex

Pediatric Blood and Cancer

Volumn 55, Issue 6, 2010, Pages 1185-1186

  Sarper, Nazan ^a   Zengin, Emine ^a   Kiliç, Suar Çaki ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Bone marrow failure; Dyskeratosis congenita; Dystrophic nails; TINF2

Indexed keywords

METHYLPREDNISOLONE; OXYMETHOLONE;

ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CHILD; DYSKERATOSIS CONGENITA; ERYTHROCYTE TRANSFUSION; GENE; GENE MUTATION; GINGIVA BLEEDING; HUMAN; MALE; NAIL DYSTROPHY; ONYCHOMYCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; TINF2 GENE;

ANDROGENS; ANTI-INFLAMMATORY AGENTS; BONE MARROW DISEASES; CHILD, PRESCHOOL; DRUG COMBINATIONS; DYSKERATOSIS CONGENITA; HUMANS; MALE; METHYLPREDNISOLONE; MUTATION; TELOMERE-BINDING PROTEINS;

EID: 77958603527     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22624     Document Type: Article

References (10)

1. Savage SA, Alter BP. The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev 2008; 129: 35-47.
2. Walne AJ, Vulliamy T, Beswick R, et al. TINF2 mutations result in very short telomeres: Analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood 2008; 112: 3594-3600.
3. Kirwan M, Dokal I. Dyskeratosis congenita: A genetic disorder of many faces. Clin Genet 2008; 73: 103-112.
4. Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol 2009; 145: 164-172.
5. Walne AJ, Dokal I. Dyskeratosis congenita: A historical perspective. Mech Ageing Dev 2008; 129: 48-59.
6. Savage SA, Giri N, Baeloccher GM, et al. TINF2 a component of shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet 2008; 82: 501-509.
7. Savage SA, Dokal I, Armanios M, et al. Dyskeratosis congenita: The first NIH clinical research workshop. Pediatr Blood Cancer 2009; 53: 520-523.
8. Erduran E, Hacisalihoglu S, Ozoran Y. Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. J Pediatr Hematol Oncol 2003; 25: 333-335.
9. Psaila B, Petrovic A, Page LK, et al. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): Study of 40 cases. Blood 2009; 114: 4777-4783.
10. Nazir S, Sayani N, Phillips PH. Retinal hemorrhages in a patient with dyskeratosis congenita. J AAPOS 2008; 12: 415-417.